File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety

TitlePembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety
Authors
Chan, SYTKhong, PLKwong, YL
Issue Date2016
Citation
Annals of Hematology, 2016 How to Cite?
DOI: http://dx.doi.org/10.1007/s00277-016-2764-1
Persistent Identifierhttp://hdl.handle.net/10722/234558
ISSN
0939-5555
2021 Impact Factor: 4.030
2020 SCImago Journal Rankings: 1.079
ISI Accession Number ID
WOS:000387353500024

 

DC FieldValueLanguage
dc.contributor.authorChan, SYT-
dc.contributor.authorKhong, PL-
dc.contributor.authorKwong, YL-
dc.date.accessioned2016-10-14T13:47:40Z-
dc.date.available2016-10-14T13:47:40Z-
dc.date.issued2016-
dc.identifier.citationAnnals of Hematology, 2016-
dc.identifier.issn0939-5555-
dc.identifier.urihttp://hdl.handle.net/10722/234558-
dc.languageeng-
dc.relation.ispartofAnnals of Hematology-
dc.titlePembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety-
dc.typeArticle-
dc.identifier.emailChan, SYT: drtchan@hku.hk-
dc.identifier.emailKhong, PL: plkhong@hku.hk-
dc.identifier.emailKwong, YL: ylkwong@hkucc.hku.hk-
dc.identifier.authorityKhong, PL=rp00467-
dc.identifier.authorityKwong, YL=rp00358-
dc.identifier.doi10.1007/s00277-016-2764-1-
dc.identifier.scopuseid_2-s2.0-84980047882-
dc.identifier.hkuros268115-
dc.identifier.eissn1432-0584-
dc.identifier.isiWOS:000387353500024-
dc.identifier.issnl0939-5555-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats